AEON Biopharma (AEON) Other Working Capital Changes (2022 - 2025)
AEON Biopharma (AEON) posted Other Working Capital Changes of $940000.0 for Q4 2025, up 18700.0% sequentially from $5000.0 in Q3 2025.
AEON Biopharma (AEON) Other Working Capital Changes (2022 - 2025) Analysis & Trends
AEON Biopharma has reported Other Working Capital Changes for 4 years, with the latest figure at $940000.0 in Q4 2025.
- Quarterly Other Working Capital Changes changed N/A year-over-year to $940000.0 in Q4 2025, while the trailing twelve-month figure through Dec 2025 was $952000.0 (up 920.69% YoY) and the FY2025 annual result came in at $952000.0, up 893.33% from the prior year.
- Other Working Capital Changes improved to $940000.0 in Q4 2025 per AEON's latest filing, from $5000.0 in the prior quarter.
- Over five years, Other Working Capital Changes peaked at $363000.0 in Q3 2023 and troughed at -$1.1 million in Q4 2025.
- A 4-year average of -$155400.0 and a median of -$88500.0 in 2024 frame the typical range for Other Working Capital Changes.
- The sharpest annual moves came in 2024 and 2025: Other Working Capital Changes tumbled 60.0% in 2024, then surged 106.9% in 2025.
- Over 4 years, Other Working Capital Changes stood at $5000.0 in 2022, then rose by 20.0% to $6000.0 in 2023, then tumbled by 1066.67% to -$58000.0 in 2024, then surged by 1720.69% to $940000.0 in 2025.
- According to Business Quant data, Other Working Capital Changes over the past three periods registered $940000.0, $5000.0, and $4000.0 for Q4 2025, Q3 2025, and Q2 2025 respectively.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.71 Bn | 131.86 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 86.55 Bn | 78.55 Bn | 3.93 Bn |
| 3 | Argenx Se | 65.26 Bn | 60.07 Bn | 1.37 Bn |
| 4 | Moderna | 59.81 Bn | 54.67 Bn | 52.00 Mn |
| 5 | BeOne Medicines | 42.16 Bn | 37.06 Bn | 1.53 Bn |
| 6 | Alnylam Pharmaceuticals | 31.87 Bn | 28.56 Bn | 992.69 Mn |
| 7 | BioNTech SE | 28.13 Bn | 9.74 Bn | 668.28 Mn |
| 8 | Insmed | 27.53 Bn | 26.37 Bn | 358.27 Mn |
| 9 | Royalty Pharma | 27.31 Bn | 26.47 Bn | - |
| 10 | AEON Biopharma | 9.73 Mn | 6.30 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | -1.09 Mn |
| Dec 31, 2025 | -1.09 Mn |
| Dec 31, 2025 | -1.09 Mn |
| Sep 30, 2025 | -338,000.00 |
| Sep 30, 2025 | -338,000.00 |
| Sep 30, 2025 | -338,000.00 |
| Jun 30, 2025 | -53,000.00 |
| Jun 30, 2025 | -53,000.00 |
| Jun 30, 2025 | -53,000.00 |
| Mar 31, 2025 | 298,000.00 |
| Mar 31, 2025 | 298,000.00 |
| Mar 31, 2025 | 298,000.00 |
| Dec 31, 2024 | -257,000.00 |
| Dec 31, 2024 | -257,000.00 |
| Dec 31, 2024 | -257,000.00 |
| Jun 30, 2024 | -363,000.00 |
| Jun 30, 2024 | -363,000.00 |
| Jun 30, 2024 | -363,000.00 |
| Mar 31, 2024 | -124,000.00 |
| Mar 31, 2024 | -124,000.00 |